Ikena Oncology, Inc.

NASDAQ:IKNA

1.71 (USD) • At close September 19, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q4
Omzet 000.6591.1852.0045.3135.456.4020.3823.38420.2173.7463.5493.4740.0652.8293.0733.2272.804
Kosten van de omzet 0.0920.2190.3050.2420.5860.5680.38118.8515.48814.34312.33813.37511.37410.02123.4027.2186.3347.8935.964
Brutowinst -0.092-0.2190.3540.9431.4184.7455.069-12.448-15.106-10.9597.879-9.629-7.825-6.547-23.337-4.389-3.261-4.666-3.16
Brutowinstmarge 000.5370.7960.7080.8930.93-1.944-39.545-3.2380.39-2.57-2.205-1.885-359.031-1.551-1.061-1.446-1.127
Onderzoek- en ontwikkelingskosten 9.749.42613.9691.18515.17215.55215.63918.8515.48814.34312.33813.37511.37410.02123.4027.2186.3347.8935.964
Algemene en administratieve kosten 5.3085.9998.2936.0345.3225.2764.9255.4285.8456.0035.0874.8934.8623.1732.7161.8441.7982.512.283
Verkoop- en marketingkosten 00-00000000000000000
Verkoop-, algemene en administratieve kosten 5.3085.9998.2936.0345.3225.2764.9255.4285.8456.0035.0874.8934.8623.1732.7161.8441.7982.512.283
Overige kosten 0.235-0.007-0.01413.469-0.0060.5660.124-0.038-0.047-0.0490.0050.0070.0060.0040.0020.0110.0210.2310
Bedrijfskosten 15.04815.42522.26220.68820.49420.82820.56424.27821.33320.34617.42518.26816.23613.19426.1189.0628.13210.4031.948
Bedrijfsresultaat -15.14-15.644-21.908-19.503-18.49-15.515-15.114-17.876-20.951-16.9622.792-14.522-12.687-9.72-26.053-6.233-5.059-7.176-5.443
Bedrijfsresultaat ratio 00-33.244-16.458-9.227-2.92-2.773-2.792-54.846-5.0120.138-3.877-3.575-2.798-400.815-2.203-1.646-2.224-1.941
Totaal overige inkomsten en kosten netto 1.472-0.4752.2572.161.3751.2961.0170.5380.460.1230.0050.0070.0060.0040.0020.0110.0210.2310.335
Inkomen voor belasting -13.668-16.119-19.651-17.343-17.115-14.219-14.097-17.338-20.491-16.8392.797-14.515-12.681-9.716-26.051-6.222-5.038-6.945-5.108
Inkomen voor belasting ratio 00-29.819-14.635-8.54-2.676-2.587-2.708-53.641-4.9760.138-3.875-3.573-2.797-400.785-2.199-1.639-2.152-1.822
Belastingkosten 0.0620.027-0.162-0.242-1.381-1.296-1.017-0.538-0.46-0.123-0.3060.4210.273-0.27300.392000
Nettowinst -13.73-16.146-19.489-17.343-17.115-12.923-13.08-16.8-20.031-16.7162.797-14.515-12.681-9.716-26.051-6.222-5.038-6.945-5.108
Nettowinstmarge 00-29.574-14.635-8.54-2.432-2.4-2.624-52.437-4.940.138-3.875-3.573-2.797-400.785-2.199-1.639-2.152-1.822
WPA (Winst Per Aandeel) -0.28-0.33-0.41-0.4-0.44-0.36-0.36-0.46-0.55-0.460.078-0.4-0.35-2.52-1.86-0.44-0.36-0.5-1.93
Verwaterde WPA -0.28-0.33-0.41-0.4-0.44-0.36-0.36-0.46-0.55-0.460.078-0.4-0.35-2.52-1.86-0.44-0.36-0.5-1.93
EBITDA -15.048-15.425-21.603-19.503-19.629-15.284-14.904-17.663-20.803-16.7822.955-14.522-11.974-9.631-25.978-6.233-4.516-7.102-5.378
EBITDA ratio 00-32.781-16.458-9.795-2.877-2.735-2.759-54.458-4.9590.146-3.877-3.374-2.772-399.662-2.203-1.47-2.201-1.918